返回 Agenda
Module 6: Phase 4 and Life Cycle Management
Session Chair(s)
Courtland R. LaVallee, MBA
Executive Director, Project Management
Dynavax Technologies, United States
Eileen Girten, MS
Medical Writing Therapeutic Area Lead
Pfizer, United States
- Product Life Cycle
- Product Enhancement
- Phase 4Studies
- New Indications
- New Dosage Forms